Jonsson Comprehensive Cancer Center
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
top
The Jonsson Comprehensive Cancer Center (JCCC) is a cancer research center at University of California, Los Angeles.
Contents
• History
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
History
The center was originated by UCLA scientists and volunteers who began working together in the late 1960s.cite-ref-nci-1-0[1] The center was formally established in 1974 and was designated as a comprehensive cancer center by the National Cancer Institute in 1976.cite-ref-nci-1-1[1]cite-ref-hubell-2-0[2] The namesake of the center is the Jonsson family; entrepreneur and philanthropist Kenneth Alan Jonsson (the son of Texas Instruments co-founder J. Erik Jonsson), along with his wife Diana Gordon Jonsson, made a $1 million gift for UCLA in 1975 to establish the center, and continued to financially support the center over a period of decades.cite-ref-3[3]cite-ref-4[4]
Joseph W. Cullen served as a deputy director of the center.cite-ref-5[5]
Organization, activities, and funding
The center employs over 500 physicians and scientists, who engage in clinical activities (i.e., cancer treatment), education, research (basic and clinical), and cancer prevention.cite-ref-nci-1-2[1]cite-ref-hubell-2-2[2]cite-ref-7[7]
Although based at UCLA, the center has clinics elsewhere in California, in Westwood, Santa Monica, Alhambra, Irvine, Pasadena, Porter Ranch, Santa Clarita, and Simi Valley.cite-ref-hubell-2-3[2]
The center is known for its research on breast and ovarian cancer.cite-ref-hubell-2-4[2] JCCC scientists developed palbociclib (PD 0332991), a breast-cancer drug that was in phase III clinical trials as of 2015.cite-ref-hubell-2-5[2] JCCC scientists also identified IGF-1 as a pathway as one pathway for the growth of tumors.cite-ref-hubell-2-6[2]
In 2013, U.S. News & World Report ranked JCCC as #11 nationally among cancer centers.cite-ref-hubell-2-7[2] In 2015, the center ranked #6.cite-ref-8[8]
In 2023, U.S. News & World Report ranked JCCC #4 nationally and #1 in California among cancer centers.cite-ref-9[9]
References
cite-note-nci-11. ↑ Jonsson Comprehensive Cancer Center: University of California at Los Angeles, Los Angeles, California, National Cancer Institute (accessed August 22, 2016).
cite-note-hubell-22. ↑ Anne Hubell, "University of California, Los Angeles, Jonsson Comprehensive Cancer Center" in The SAGE Encyclopedia of Cancer and Society (SAGE Publications: 2d ed. 2015; ed. Graham A. Colditz), pp. 1228-29.
cite-note-33. ↑ Obituary: Kenneth Alan Jonsson dies at 79; co-founder of cancer center at UCLA, Los Angeles Times (April 4, 2010).
cite-note-44. ↑ Mary Rourke, Diana G. Jonsson, 76; Helped Found Prominent Cancer Center at UCLA, Los Angeles Times (May 12, 2006).
cite-note-55. ↑ Obituary: Joseph W. Cullen, 53, a Cancer Researcher, New York Times (November 28, 1990).
cite-note-66. ↑ About the Jonsson Cancer Center Foundation, Jonsson Comprehensive Cancer Center (accessed August 22, 2016).
cite-note-77. ↑ "UCLA Jonsson Comprehensive Cancer Center : A Comprehensive Cancer Center". cancer.ucla.edu.
cite-note-88. ↑ UCLA's Jonsson Comprehensive Cancer Center once again ranks among top 10 cancer centers nationwide (press release), Jonsson Comprehensive Cancer Center (July 21, 2015).
cite-note-99. ↑ citerefharder2023Harder, Ben (August 1, 2023). "America's Best Hospitals: the 2023-2024 Honor Roll and Overview".
External links